Albuterol - Control
PreclinicalSmall molecule
Albuterol - Control is one of 20 small molecule programs targeting Wheezing. It is currently in Preclinical.
1
Indications
1
Total Trials
0
Active Trials
19
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
26 competitors in Wheezing
#DrugCompanyPhaseTrials
1Flovent
GSKApproved
Spiriva
Boehringer IngelheimApproved
Deltasone
PPfizer's Upjohn has merged with Mylan to form Viatris Inc.
Approved
Deltavit
HHyundai Pharmaceutical Co., LTD.
Approved
Salbutamol
GSKApproved
Qvar
Chiesi Farmaceutici S.p.A.Phase 3
Pulmicort
SSalix
Phase 3
Zithromax
PPfizer's Upjohn has merged with Mylan to form Viatris Inc.
Phase 3
Prednisolone Sodium Phosphate
UUniversity of Oulu
Approved
Nebulized Budesonide
DDeborah Gentile
Approved
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Albuterol - Control. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- UUniversity of Sao Paulo